169165 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on sub-cellular localization
INHIBITION OF A TRIPARTITE VOR PROTEIN COMPLEX IN MULTICELLULAR ORGANISMS
#2SYSTEMS AND METHODS FOR OPTOGENETIC ACTIVATION AND MONITORING
#3MASS-TAG LABELING OF THE CELLULAR SECRETOME
#4METHOD FOR MEASURING CELLULAR UPTAKE OF MOLECULES
#5OBLIQUE LINE SCANNER SYSTEMS AND METHODS FOR HIGH THROUGHPUT SINGLE MOLECULE TRACKING IN LIVING CELLS
#6SYSTEMS AND METHODS FOR HIGH THROUGHPUT SINGLE MOLECULE TRACKING IN LIVING CELLS
#7SYSTEMS AND METHODS FOR HIGH THROUGHPUT SINGLE MOLECULE TRACKING IN LIVING CELLS
#8GENETICALLY CONTROLLED NANOSCOPY CONTRAST-GENERATING UNITS, GENETICALLY CONTROLLED STRUCTURAL ELEMENTS, GENETICALLY CONTROLLED SCAFFOLDS, NANOBIOMATERIAL BASED THEREON, AND USE THEREOF IN NANOSOCOPY METHODS
#9METHODS FOR PREDICTING THE USEFULNESS OF PROTEINS OR PROTEIN FRAGMENTS FOR IMMUNOTHERAPY
#10Methods and Compositions for Treating or Preventing Neurological Injury or Neurological Disorders
#11EXPRESSION SYSTEMS FOR THE ALPHA6-CONTAINING NICOTINIC ACETYLCHOLINE RECEPTOR AND METHODS OF USE THEREOF
#12BIOASSAYS TO MEASURE THE SYNERGISTIC ANTIBODY-DEPENDENT ENHANCEMENT (ADE) EFFECT OF SARS-CoV-2 NEUTRALIZING ANTIBODIES
#13Rust Resistance Gene
#14ASSAY FOR SARS-CoV-2 INFECTION OF VULNERABLE HUMAN CELLS
#15IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
#16BIOMIMETIC LIPOSOMES AND METHODS OF MAKING AND USING THE SAME
#17CLEARANCE ASSAY
#18Method to Evaluate the Capability of Compounds on the Trapping of Proteins
#19TYROSINE, TRYPTOPHAN AND PHENYLALANINE AS mTOR AGONISTS MEDIATING PROTEASOME DYNAMICS, COMPOSITIONS, METHODS AND USES THEREOF IN THERAPY, AND PROGNOSTIC METHODS FOR DRUG-RESISTANCE
#20STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS, AND USES THEREOF
#21SYSTEM
#22BETA-ARRESTIN COMPOSITIONS AND ASSOCIATED METHODS
#23Rust resistance gene
#24DETERMINING DRUG EFFECTS USING COMBINATION OF MEASUREMENTS
#25Probe and Method for Detecting Membrane-Associated Molecules in Living Cells
#26Screening method for effective target - E3 ligase combinations
#27ROCK INHIBITORS FOR USE IN TREATING OR PREVENTING PULMONARY EDEMA
#28NOVEL ION CONDUCTING CHANNEL FUSION SUBUNITS AND METHODS OF USE THEREOF
#29MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#30MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#31METHODS FOR IDENTIFYING VIRAL INFECTIONS AND FOR ANALYZING EXOSOMES IN LIQUID SAMPLES BY RAMAN SPECTROSCOPY
#32GAMMA-SECRETASE STABILIZING COMPOUND SCREENING ASSAY
#33XBP1 ISOFORM MULTIPLEX ASSAY
#34Methods and compositions for diagnosing and treating, germline mismatch repair deficiencies, lynch syndrome and assessing germline risks of cancer
#35SYSTEMS AND METHODS FOR OPTOGENETIC ACTIVATION AND MONITORING
#36METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING, GERMLINE MISMATCH REPAIR DEFICIENCIES, LYNCH SYNDROME AND ASSESSING GERMLINE RISKS OF CANCER
#37PEPTIDE-BASED NON-PROTEINACEOUS CARGO DELIVERY
#38METHODS OF IDENTIFYING PARKIN-MEDIATED MITOPHAGY ACTIVATING AGENTS
#39SLEEP MODULATION AGENT
#40TFR-SPECIFIC BINDING MOIETIES AND TRANSCYTOSIS METHOD TO SELECT VNARS THAT CROSS CELLULAR BARRIERS
#41INHIBITION OF A TRIPARTITE VOR PROTEIN COMPLEX IN MULTICELLULAR ORGANISMS
#42Method of predicting the likelihood of success of gene therapy
#43METHOD FOR ANALYZING IMMUNE CELLS
#44Method for measuring cellular uptake of molecules
#45IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
#46Method of high throughput screening of chemical compounds suppressing nucleolar hypertrophy
#47METHODS OF TREATING NEUROLOGICAL DISEASES AND DISORDERS
#48Methods of BH3 profiling
#49Chemical probe-dependent evaluation of protein activity and uses thereof
#50Rust resistance gene
#51GENETICALLY ENCODED FLUORESCENT-IRON FERRITIN NANOPARTICLE PROBES FOR DETECTING AN INTRACELLULAR TARGET BY FLUORESCENT AND ELECTRON MICROSCOPY
#52Method of assessing ABC transporter activity using fluorescent dye accumulation assay
#53METHODS OF MODULATING PROTEIN EXOCYTOSIS AND USES OF SAME IN THERAPY
#54USE OF P97 AS AN ENZYME DELIVERY SYSTEM FOR THE DELIVERY OF THERAPEUTIC LYSOSOMAL ENZYMES
#55BIOSENSORS FOR MONITORING BIOMOLECULE LOCALIZATION AND TRAFFICKING IN CELLS
#56Cell analysis system, cell analysis program and cell analysis method
#57Method of identifying a compound which affects the multienzyme metabolic assembly of glucose metabolism and its association with cell cycle progression in cancer cells
#58DIAGNOSTIC AND SCREENING METHODS FOR ATOPIC DERMATITIS
#59Fluorescent fusion polypeptide capable of detecting phosphorylation of cellular membrane receptors by GRKs (G-protein receptor kinases) and/or receptor tyrosine kinases (RTKs)
#60COMPOSITIONS AND METHODS FOR CONTROLLING NATURAL KILLER CELL ACTIVATION AND FUNCTION
#61leukocidins, therapeutic compositions, and uses thereof
#62Immuno-based retargeted endopeptidase activity assays
#63Method of Identifying Transmembrane Protein-interacting Compounds
#64Rust resistance gene
#65Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
#66Screening method of drug candidates for treating disease using interaction between calcium and phosphatidylinositol phosphate
#67Modulators of ATP-binding cassette transporters
#68INDIRECT ASSESSMENT OF INSULIN RELEASE IN A CELL
#69Cell analysis system, cell analysis program and cell analysis method
#70Modulators of ATP-binding cassette transporters
#71Methods and reagents for determination and treatment of organotropic metastasis
#72FUSION PROTEINS AND METHODS FOR IDENTIFYING BROMODOMAIN INHIBITING COMPOUNDS
#73Method to monitor and quantify interphase nuclear envelope rupture events
#74D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS
#75Rust resistance gene
#76Method of Identifying Transmembrane Protein-interacting Compounds
#77COMPOSITIONS AND METHODS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#78Identification of enzyme activity through determination of its localization
#79Method for treating a cancer patient based on atomic therapeutic indexes and radiation
#80METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS
#81USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS
#82Diagnostic and screening methods for atopic dermatitis
#83leukocidins, therapeutic compositions, and uses thereof
#84Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
#85Fluorescent fusion polypeptide, encoding nucleic acid, and cell comprising said polypeptide
#86Fluorescent fusion polypeptide, encoding nucleic acid, and cell comprising said polypeptide
#87Phenotypic High-Content Assay to Evaluate Drugs
#88Method of Identifying Transmembrane Protein-interacting Compounds
#89Renilla based biosensors for monitoring biomolecule localization and trafficking in cells
#90COMPOUNDS THAT BIND DYSTROGLYCAN AND USES THEREOF
#91INHIBITORS OF MALARIAL AND HUMAN GLUCOSE TRANSPORTERS AND METHODS FOR IDENTIFYING THE INHIBITORS
#92Method of screening a candidate compound for inducing bile canalicular function disorders
#93Propeptide-luciferase fusion proteins and methods of use thereof
#94Immuno-based retargeted endopeptidase activity assays
#95Epithelial cell spheroids and methods of making and using the same
#96Advanced macromolecule transduction domain (aMTD) sequences for improvement of cell-permeability, polynucleotides encoding the same, method to identify the unique features of aMTDs comprising the same, method to develop the aMTD sequences comprising the same
#97A METHOD OF SCREENING FOR A COMPOUND CAPABLE OF STIMULATING GLUCOSE TRANSPORT INTO BROWN AND/OR BRITE ADIPOCYTES OF A MAMMAL, A KIT FOR USE IN SUCH A METHOD
#98Cell information obtaining method and cell information obtaining apparatus
#99METHOD FOR PREDICTING TOXICITY OF A COMPOUND BASED ON NUCLEAR FACTOR-kB TRANSLOCATION
#100CELL LINE, SYSTEM AND METHOD FOR OPTICAL CONTROL OF SECONDARY MESSENGERS
#101Screening method, a kit, a method of treatment and a compound for use in a method of treatment
#102Cell penetrating protein adaptor molecules and their application in research and medicine
#103Cell analysis system, cell analysis program and cell analysis method
#104Modulators of ATP-binding cassette transporters
#105Methods of BH3 profiling
#106Rust resistance gene
#107MITOCHONDRIA AND HUMAN IMMUNODEFIENCY VIRUS TYPE 1 TRANSMISSION
#108PROTEASOME INHIBITORS AND USES THEREOF
#109Method of monitoring cellular trafficking of peptides
#110Antigen binding protein and its use as addressing product for the treatment of cancer
#111Method for measuring cell-to-cell transmission of α-synuclein aggregates using bimolecular fluorescence complementation system and method for screening a substance for preventing or treating neurodegenerative disease using the same
#112TRANSMEMBRANE PROTEINS AS BIOSENSORS
#113Methods for treating ADHD and bipolar disorder using a membrane potential ratio test
#114INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS
#115Systems and methods for detection of cellular stress
#116CORRECTORS ACTING THROUGH MSD1 OF CFTR PROTEIN
#117Compositions and methods for modulating c-Rel-dependent cytokine production
#118FUSION PROTEINS AND METHODS FOR IDENTIFYING BROMODOMAIN INHIBITING COMPOUNDS
#119Method to evaluate the tissue targeting of a molecule of interest
#120Intranuclear protein transduction through a nucleoside salvage pathway
#121MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#122Immuno-based retargeted endopeptidase activity assays
#123Inhibitors of calcium-activated chloride channels
#124Epithelial tissue model
#125IDENTIFICATION OF ENZYME ACTIVITY THROUGH DETERMINATION OF ITS LOCALIZATION
#126Methods for detecting and monitoring endocrine disrupting chemicals (EDCs)
#127Cell line, system and method for optical control of secondary messengers
#128Fluorescent fusion polypeptide
#129Diagnostic and screening methods for atopic dermatitis
#130Retinal pigment epithelial primary cell culture system producing subcellular deposits
#131Modulators of ATP-Binding Cassette Transporters
#132Genetically encoded probe for quantification of lactate and methods for quantifying metabolic rates and lactate transport
#133Modulators of ATP-Binding Cassette Transporters
#134MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#135Cyanochrome fluorophores
#136Antigen binding protein and its use as addressing product for the treatment of cancer
#137Methods of Screening for Activation Deaminase Inhibitors Through Nuclear Import Inhibitors
#138DETECTION OF PROTEIN TRANSLOCATION BY BETA-GALACTOSIDASE REPORTER FRAGMENT COMPLEMENTATION
#139Modulators of ATP-binding cassette transporters
#140METHOD FOR DETECTING COMPOUND-BINDING PROTEIN
#141Remedy for diabetes
#142Propeptide-luciferase fusion proteins and methods of use thereof
#143Genes and polypeptides relating to breast cancers
#144Cell model and method for screening c-Fms kinase inhibitors
#145Methods and assays for treating filoviridae infections
#146Quantitative genetically encoded optical reporter construct
#147Cell line, system and method for optical control of secondary messengers
#148Kits for detecting and monitoring endocrine disrupting chemicals (EDCs)
#149CELLS HAVING DISRUPTED EXPRESSION OF PROTEINS INVOLVED IN ADME AND TOXICOLOGY PROCESSES
#150Proteasome inhibitors and uses thereof
#151Method for detecting interactions between two and more biological macromolecules
#152Systems and methods for detection of cellular stress
#153leukocidins, therapeutic compositions, and uses thereof
#154Method of identifying transmembrane protein-interacting compounds
#155USE OF ENDOGENOUS PROMOTERS TO EXPRESS HETEROLOGOUS PROTEINS
#156METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS
#157BIOSENSORS COMPRISING PROTEIN-BINDING DOMAINS AND FLUORESCENT PROTEINS
#158Modulators of ATP-binding cassette transporters
#159Method for testing or screening protein synthesis inhibitors
#160Modulators of ATP-Binding Cassette Transporters
#161COMPOSITIONS AND METHODS FOR MODULATING C-REL-DEPENDENT CYTOKINE PRODUCTION
#162Method for measuring autophagy
#163COMPOUNDS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
#164METHODS AND KITS FOR REGULATING INTRACELLULAR TRAFFICKING OF A TARGET PROTEIN
#165COMPOUNDS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
#166ALTERING MEMORY BY AFFECTING STAUFEN FUNCTION
#167PROTEASOME INHIBITORS AND USES THEREOF
#168Detection of protein translocation by beta-galactosidase reporter fragment complementation
#169Genetically encoded calcium indicator polypeptides and nucleic acids encoding same
#170Method for detecting membrane protein internalization
#171G PROTEIN-COUPLED RECEPTOR ANTAGONIST AND ITS USE FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE
#172INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS
#173leukocidins, therapeutic compositions, and uses thereof
#174METHODS FOR TESTING BINDING OF A LIGAND TO A G PROTEIN-COUPLED RECEPTOR
#175Dynamic visualization of expressed gene networks in living cells
#176NEW TREATMENT OF AUTOIMMUNE CONDITIONS
#177SCREENING METHODS FOR HEAT-SHOCK RESPONSE MODULATORS
#178ASSAY SYSTEM
#179Genes and polypeptides relating to breast cancers
#180Use of Activating Transcription Factor-2 (ATF2) for Detecting Skin Cancer
#181Cell line, system and method for optical control of secondary messengers
#182CENTROSOME-ASSAY
#183Modulators of ATP-binding cassette transporters
#184Modulators of ATP-binding cassette transporters
#185ENCAPSULATED QUANTUM DOT
#186ALTERING MEMORY BY AFFECTING STAUFEN
#187METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION
#188INHIBITORS OF CALCIUM-ACTIVATED CHLORIDE CHANNELS
#189SCREENING ASSAY TO IDENTIFY CORRECTORS OF PROTEIN TRAFFICKING DEFECTS
#190Monitoring of Intercellular Mitochondorial Polarization
#191METHOD FOR SCREENING AN INHIBITORY AGENT OF HBV PROLIFERATION BY USING THE INTERACTION BETWEEN HBV CAPSID AND SURFACE PROTEINS BASED ON CELLULAR IMAGING
#192Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
#193Cyanochrome fluorophores
#194Toll-Like Receptor 9 Modulators
#195Methods and compositions for modulating BCL-2 family polypeptides
#196Detection of sub-cellular compartment localization of a molecule using a reduced affinity enzyme complementation reporter system
#197Method of identifying transmembrane protein-interacting compounds
#198Method for testing or screening protein synthesis inhibitors
#199METHOD FOR DETECTION OF A DISEASE-SPECIFIC COMBINATORIAL MOLECULAR PATTERN MOTIF IN A TISSUE SAMPLE OF A PATIENT'S SKIN
#200IN VIVO MODULATION OF NEURONAL TRANSPORT
#201NOVEL AS160-LIKE PROTEIN, TEST SYSTEMS, METHODS AND USES INVOLVING IT FOR THE IDENTIFICATION OF DIABETES TYPE 2 THERAPEUTICS
#202Method of determining sperm capacitation
#203Method for Identifying Modulators of Gamma Secretase or Notch
#204Immuno-based retargeted endopeptidase activity assays
#205Methods for Diagnosing and Treating Endoplasmic Reticulum (ER) Stress Diseases
#206Probes for detecting protein nuclear transport and method for detecting and quantifying protein nuclear transport using the same
#207Method for screening compounds to determine those which enhance islet cell activity and/or survival and uses therefor
#208Altering memory by affecting staufen function
#209Methods of detecting and monitoring cancer using 3D analysis of centromeres
#210METHOD FOR IDENTIFICATION OF SOMATIC STEM CELLS
#211Intracellular DNA receptor
#212METHOD FOR DETECTING INTERACTIONS BETWEEN TWO AND MORE BIOLOGICAL MACROMOLECULES
#213Modulators of ATP-binding cassette transporters
#214Protein-Protein Interaction Biosensors and Methods of Use Thereof
#215Remedy for diabetes
#216Generic Assay for Monitoring Endocytosis
#217Methods for determining signal transduction activity in tumors
#218INTEGRATED SCREENING ASSAYS AND METHODS OF USE
#219Treatment of insulin resistance by administering an acid-sensing ion channel 3 inhibitor
#220Intracellular targeting of molecules via syndecan-4
#221Modulators of ATP-binding cassette transporters
#222Modulators of ATP-binding cassette transporters
#223Single-cell biosensor for the measurement of GPCR ligands in a test sample
#224TORC POLYNUCLEOTIDES AND POLYPEPTIDES AND METHOD OF USE
#225Method for screening the receptor-ligand binding in live cell
#226Vitro method of detecting and/or diagnosing cancer using UV light based DNA image cytometry
#227Fluorescent protein
#228Identification of Novel Protein Targets on the Surface of Stressed Cells
#229Indole derivatives as CFTR modulators
#230SCREENING PROTEINASE MODULATORS USING A CHIMERIC PROTEIN AND SKI-I PROPROTEIN CONVERTASE SUBSTRATES AND INHIBITORS
#231Method for identifying compounds that affect a transport of a protein through a membrane trafficking pathway
#232Method for diagnosing alzheimer's disease
#233Method of identifying transmembrane protein-interacting compounds
#234Single-cell biosensor for the measurement of GPCR ligands in a test sample
#235KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF A CALRETICULIN PROTEIN TO A CELLULAR MEMBRANE
#236METHOD FOR EXTRACTING QUANTITATIVE INFORMATION RELATING TO AN INFLUENCE ON A CELLULAR RESPONSE
#237METHOD FOR SCREENING FERTILITY AND NEW COMPOUNDS OR MOLECULES, USING CRT OR ERP57 TRANSLOCATION
#238QUANTITATIVE DETERMINATION OF BCL10
#239Screening G protein-coupled receptor antagonists for methods of treating Alzheimer's disease
#240Viral/bacterial toxin polypeptides and methods of using same
#241Intranuclear protein transduction through a nucleoside salvage pathway
#242Signalling Assay and Cell Line
#243COMPOSITIONS AND METHODS FOR MODULATING C-REL-DEPENDENT CYTOKINE PRODUCTION
#244METHODS AND MEANS FOR INFLUENCING INTERCELLULAR COMMUNICATION AND INTERCELLULAR ORGANELLE TRANSPORT
#245Treatment of insulin resistance
#246Screening method for Staufen activity in neurons
#247USE OF MDCK CELL LINE TO PREDICT CORNEAL PENETRATION OF DRUGS
#248Cellular antagonists of GPCR physiology
#249Modulators of ATP-binding cassette transporters
#250System for cell-based screening
#251Interaction of Colon Cancer Related Gene C200RF20 With P120
#252Methods for promoting, inhibiting and detecting toxin entry into cells
#253Methods For Diagnosing And Treating Endoplasmic Reticulum (er) Stress Diseases
#254Methods Of Screening Compositions For G Protein-Coupled Receptors Aganist Agonists
#255Probes for detecting protein nuclear transport and method for detecting and quantifying protein nuclear transport using the same
#256Split protein self complementing fragments, systems, and methods of use thereof
#257Method for detecting presence of toxic material within sample
#258Novel translocation assay
#259Chemical address tags
#260Detection of intracellular enzyme complex
#261Screening of compounds for GAT2 transporter activity
#262Novel methods and apparatus for cell based microarray assays
#263Methods and device for adhesive control of internal cell organisation
#264Neuregulin protein regulation of synaptic proteins
#265Methods for modulating transcriptional activation using mint proteins
#266Methods for assaying for antidepressant therapy markers
#267Mitotic index assay
#268Method for identification of somatic stem cells
#269Method for detection of a disease-specific combinatorial molecular pattern motif in a tissue sample of a patient's skin
#270Inhibition of the β3 subunit of L-type Cachannels
#271Calcium biosensor polypeptides and methods of use
#272In vivo modulation of neuronal transport
#273Methods to increase the capacity of high content cell-based screening assays
#274Method for screening compounds for those that modulate transducers of regulated CREB activity
#275Methods and compositions that affect melanogenesis
#276Compounds acting at the centrosome
#277Toll-like receptor 9 modulators
#278Toll-like receptor assays
#279Methods for identifying new drug leads and new therapeutic uses for known drugs
#280Method for identifying antimicrobial molecules which interfere with apolipoprotein N-acyltransferase activity
#281Modulators of ATP-binding cassette transporters
#282Pharmacological profiling of drugs with cell-based assays
#283System to detect inducible translocation
#284Methods for measuring chloride channel conductivity
#285ENT1 transporters expressed in cancer cells
#286SMVT transporters expressed in cancer cells
#287Method of identifying transmembrane protein-interacting compounds
#288Detection of protein translocation by beta-galactosidase reporter fragment complementation
#289Compositions and methods for modulating c-Rel-dependent cytokine production
#290Compositions and methods for the identification of protein interactions in vertebrate cells
#291Functional screening method
#292Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
#293Toll-like receptor 9 modulators
#294Use of MDCK cell line to predict corneal penetration of drugs
#295Cell population provided with identification codes and method of screening cell population
#296Toll-like receptor assays
#297Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
#298Methods and agents for enhancing bone formation or preventing bone loss
#299Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
#300Altering memory by affecting STAUFEN function